Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor
HOFMANN, W.-K, GANSER, A, HOELZER, D, SEIPELT, G, OTTMANN, O. G, ZANDER, C, GEISSLER, G, HOFFMANN, K, HÖFFKEN, K, FISCHER, J. T, ISELE, G
Published in Annals of hematology (01.03.1999)
Published in Annals of hematology (01.03.1999)
Get full text
Journal Article